Digestive & Intestinal Remedies (Pharmacies) - Nordics

  • Nordics
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$115.00m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.04%, resulting in a market volume of US$121.10m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$4.10 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Nordics is experiencing steady growth, driven by increasing customer preferences for natural and organic products, as well as a growing awareness of digestive health. Customer preferences in the Nordics are shifting towards natural and organic remedies for digestive and intestinal issues. Consumers in the region are becoming more health-conscious and are actively seeking out products that are free from artificial ingredients and chemicals. This preference for natural remedies is driving the demand for herbal and plant-based digestive and intestinal remedies in pharmacies. Another customer preference driving the market is the growing awareness of digestive health. Consumers in the Nordics are increasingly recognizing the importance of maintaining a healthy digestive system and are seeking products that can help alleviate common digestive issues such as bloating, indigestion, and constipation. This has led to an increased demand for probiotics and other digestive health supplements in the market. In addition to these customer preferences, there are several trends in the Digestive & Intestinal Remedies (Pharmacies) market in the Nordics. One trend is the increasing availability of digestive health products in pharmacies. Pharmacies in the region are expanding their product offerings to cater to the growing demand for digestive and intestinal remedies. This includes a wider range of natural and organic products, as well as specialized supplements for specific digestive issues. Another trend is the growing popularity of online pharmacies in the Nordics. Consumers are increasingly turning to online platforms to purchase their digestive and intestinal remedies, as it offers convenience and a wider selection of products. Online pharmacies also often provide detailed product information and customer reviews, which helps consumers make informed decisions about their purchases. Local special circumstances in the Nordics also contribute to the development of the Digestive & Intestinal Remedies (Pharmacies) market. The region has a strong focus on health and wellness, with a high demand for natural and organic products. This aligns with the customer preferences for natural remedies and contributes to the growth of the market. Additionally, the Nordics have a well-developed healthcare system, which includes a strong network of pharmacies. This infrastructure supports the availability and accessibility of digestive and intestinal remedies in the market. Underlying macroeconomic factors also play a role in the development of the market. The Nordics have a stable economy and a high standard of living, which allows consumers to prioritize their health and wellbeing. Additionally, the region has a high level of healthcare expenditure, which contributes to the demand for healthcare products, including digestive and intestinal remedies. Overall, the Digestive & Intestinal Remedies (Pharmacies) market in the Nordics is experiencing growth due to customer preferences for natural and organic products, increasing awareness of digestive health, and the availability of a wide range of products in pharmacies. The market is further supported by local special circumstances and underlying macroeconomic factors in the region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)